Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / TOI - Constellation Software Inc. and Topicus.com Inc. Announce Results for Topicus.com Inc. for the First Quarter Ended March 31 2024


TOI - Constellation Software Inc. and Topicus.com Inc. Announce Results for Topicus.com Inc. for the First Quarter Ended March 31 2024

TORONTO, May 01, 2024 (GLOBE NEWSWIRE) -- Topicus.com Inc. (TSXV:TOI) in a joint release with Constellation Software Inc. (TSX:CSU) today announced financial results for Topicus.com Inc. (“Topicus” or the “Company”) for the first quarter ended March 31, 2024. Please note that all amounts referred to in this press release are in Euros unless otherwise stated.

The following press release should be read in conjunction with the Company’s Unaudited Condensed Consolidated Interim Financial Statements for the three months ended March 31, 2024 and the accompanying notes, our Management’s Discussion and Analysis for the three months ended March 31, 2024 and the Annual Consolidated Financial Statements of Topicus.com Inc. for the year ended December 31, 2023, which we prepared in accordance with International Financial Reporting Standards (“IFRS”) and the Company’s annual Management’s Discussion and Analysis for the year ended December 31, 2023, which can be found on SEDAR+ at www.sedarplus.com and on Topicus.com Inc.’s website www.topicus.com. Additional information about Topicus.com Inc. is also available on SEDAR+ at www.sedarplus.com.

Q1 2024 Headlines:

  • Revenue increased 16% (5% organic growth) to €306.6 million compared to €264.4 million in Q1 2023.
  • Net income increased to €28.3 million (€0.22 on a diluted per share basis) from €21.1 million (€0.17 on a diluted per share basis).
  • Acquisitions were completed for aggregate cash consideration of €36.5 million (which includes acquired cash). Deferred payments associated with these acquisitions have an estimated value of €17.5 million resulting in total consideration of €54.0 million.
  • Cash flows from operations (“CFO”) increased €53.5 million to €227.5 million compared to €174.0 million in Q1 2023 representing an increase of 31%.
  • Free cash flow available to shareholders 1 (“FCFA2S”) increased €32.3 million to €133.4 million compared to €101.1 in Q1 2023.

Total revenue for the quarter ended March 31, 2024 was €306.6 million, an increase of 16%, or €42.1 million, compared to €264.4 million for the comparable period in 2023. The increase for the three-month period compared to the same period in the prior year is primarily attributable to growth from acquisitions as the Company experienced organic growth of 5% in the quarter. Organic growth is not a standardized financial measure and might not be comparable to measures disclosed by other issuers.

Net income for the quarter ended March 31, 2024 increased €7.2 million to €28.3 million compared to €21.1 million for the same period in 2023. On a per share basis, this translated into net income per basic and diluted share of €0.22 in the quarter ended March 31, 2024 compared to €0.17 for the same period in 2023.

For the quarter ended March 31, 2024, CFO increased €53.5 million to €227.5 million compared to €174.0 million for the same period in 2023 representing an increase of 31%.

For the quarter ended March 31, 2024, FCFA2S increased €32.3 million to €133.4 million compared to €101.1 million for the same period in 2023 representing an increase of 32%.

Forward Looking Statements

Certain statements herein may be “forward looking” statements that involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of Topicus or the industry to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Forward looking statements involve significant risks and uncertainties, should not be read as guarantees of future performance or results, and will not necessarily be accurate indications of whether or not such results will be achieved. A number of factors could cause actual results to vary significantly from the results discussed in the forward looking statements. These forward looking statements reflect current assumptions and expectations regarding future events and operating performance and are made as of the date hereof and Topicus assumes no obligation, except as required by law, to update any forward looking statements to reflect new events or circumstances.

Non-IFRS Measures

Free cash flow available to shareholders ‘‘FCFA2S’’ refers to net cash flows from operating activities less interest paid on lease obligations, interest paid on other facilities, credit facility transaction costs, repayments of lease obligations, dividends paid to redeemable preferred securities holders, and property and equipment purchased, and includes interest and dividends received, and the proceeds from sale of interest rate caps. The portion of this amount applicable to non-controlling interests is then deducted. Topicus believes that FCFA2S is useful supplemental information as it provides an indication of the uncommitted cash flow that is available to shareholders if Topicus does not make any acquisitions, or investments, and does not repay any debts. While Topicus could use the FCFA2S to pay dividends or repurchase shares, Topicus’ objective is to invest all of our FCFA2S in acquisitions which meet Topicus’ hurdle rate.

FCFA2S is not a recognized measure under IFRS and, accordingly, readers are cautioned that FCFA2S should not be construed as an alternative to net cash flows from operating activities.

The following table reconciles FCFA2S to net cash flows from operating activities:

Three months ended
March 31,
2024
2023
(€ in millions)
Net cash flows from operating activities
227.5
174.0
Adjusted for:
Interest paid on lease obligations
(0.5
)
(0.3
)
Interest paid on other facilities
(3.2
)
(3.1
)
Credit facility transaction costs
-
(0.1
)
Payments of lease obligations
(5.8
)
(5.3
)
Property and equipment purchased
(2.7
)
(2.0
)
215.4
163.3
Less amount attributable to
non-controlling interests
(82.0
)
(62.2
)
Free cash flow available to shareholders
133.4
101.1
Due to rounding, certain totals may not foot.


About Topicus.com Inc.

Topicus’ subordinate voting shares are listed on the Toronto Venture Stock Exchange under the symbol "TOI". Topicus acquires, manages and builds vertical market software businesses.

About Constellation Software Inc.

Constellation's common shares are listed on the Toronto Stock Exchange under the symbol "CSU". Constellation acquires, manages and builds vertical market software businesses.

For further information:
Jamal Baksh
Chief Financial Officer
(416) 861-9677
info@topicus.com
www.topicus.com

S OURCE: TOPICUS.COM INC.


Topicus.com Inc.
Condensed Consolidated Interim Statements of Financial Position
(In thousands of euros, except per share amounts. Due to rounding, numbers presented may not foot.)
Unaudited
March 31, 2024
December 31, 2023
March 31, 2023
Assets
Current assets:
Cash
254,599
179,059
197,265
Accounts receivable
175,767
134,079
143,923
Unbilled revenue
49,454
44,838
47,210
Inventories
4,516
4,517
1,481
Other assets
63,845
55,250
49,574
548,181
417,742
439,453
Non-current assets:
Property and equipment
21,363
20,030
19,685
Right of use assets
63,054
61,066
53,933
Deferred income taxes
20,326
16,412
21,850
Other assets
13,437
13,824
17,021
Intangible assets
947,417
906,082
871,290
1,065,598
1,017,415
983,778
Total assets
1,613,779
1,435,157
1,423,231
Liabilities and Shareholders' Equity
Current liabilities:
Topicus Revolving Credit Facility and current portion of term and other loans
265,221
161,077
123,871
Loan from CSI
-
-
30,361
Accounts payable and accrued liabilities
227,130
211,423
190,889
Deferred revenue
343,430
138,854
288,188
Provisions
1,535
1,708
1,081
Acquisition holdback payables
13,808
12,292
10,293
Lease obligations
21,338
20,614
18,384
Income taxes payable
23,102
20,068
14,041
895,563
566,035
677,109
Non-current liabilities:
Term and other loans
62,973
64,615
44,935
Deferred income taxes
148,142
137,155
147,205
Acquisition holdback payables
7,690
1,339
1,958
Lease obligations
42,748
41,524
36,635
Other liabilities
36,017
32,005
27,246
297,570
276,639
257,979
Total liabilities
1,193,133
842,674
935,088
Shareholders' Equity:
Capital stock
39,412
39,412
39,412
Accumulated other comprehensive income (loss)
3,016
2,390
(469
)
Retained earnings (deficit)
192,136
297,382
240,820
Non-controlling interests
186,082
253,299
208,380
420,646
592,483
488,143
Total liabilities and shareholders' equity
1,613,779
1,435,157
1,423,231


Topicus.com Inc.
Condensed Consolidated Interim Statements of Income (Loss)
(In thousands of euros, except per share amounts. Due to rounding, numbers presented may not foot.)
Unaudited
Three months ended March 31,
2024
2023
Revenue
License
9,165
6,977
Professional services
75,005
69,340
Hardware and other
5,551
2,680
Maintenance and other recurring
216,848
185,432
306,568
264,430
Expenses
Staff
173,116
150,108
Hardware
4,620
1,578
Third party license, maintenance and professional services
23,352
20,548
Occupancy
2,710
2,466
Travel, telecommunications, supplies, software and equipment
11,983
9,564
Professional fees
5,092
4,280
Other, net
4,305
6,214
Depreciation
8,012
7,296
Amortization of intangible assets
31,672
27,960
264,861
230,014
Impairment of intangible and other non-financial assets
633
-
Bargain purchase (gain)
(323
)
-
Finance and other expenses (income)
4,998
4,950
5,309
4,950
Income (loss) before income taxes
36,398
29,467
Current income tax expense (recovery)
15,083
12,328
Deferred income tax expense (recovery)
(6,998
)
(3,989
)
Income tax expense (recovery)
8,085
8,338
Net income (loss)
28,314
21,128
Net income (loss) attributable to:
Equity holders of Topicus
18,089
13,900
Non-controlling interests
10,225
7,229
Net income (loss)
28,314
21,128
Weighted average shares
Basic shares outstanding
82,195,644
81,889,764
Diluted shares outstanding
129,841,819
129,841,819
Earnings (loss) per common share of Topicus
Basic
0.22
0.17
Diluted
0.22
0.17


Topicus.com Inc.
Condensed Consolidated Interim Statements of Comprehensive Income (Loss)
(In thousands of euros, except per share amounts. Due to rounding, numbers presented may not foot.)
Unaudited
Three months ended March 31,
2024
2023
Net income (loss)
28,314
21,128
Items that are or may be reclassified subsequently to net income (loss):
Foreign currency translation differences from foreign operations and other
1,926
(796
)
Other comprehensive (loss) income for the period, net of income tax
1,926
(796
)
Total comprehensive income (loss) for the period
30,240
20,332
Total other comprehensive income (loss) attributable to:
Equity holders of Topicus
625
(237
)
Non-controlling interests
1,301
(559
)
Total other comprehensive income (loss)
1,926
(796
)
Total comprehensive income (loss) attributable to:
Equity holders of Topicus
18,714
13,663
Non-controlling interests
11,526
6,669
Total comprehensive income (loss)
30,240
20,332


Topicus.com Inc.
Condensed Consolidated Interim Statement of Changes in Shareholders' Equity (Deficiency)
(In thousands of euros, except per share amounts. Due to rounding, numbers presented may not foot.)
Unaudited
Three months ended March 31, 2024
Capital Stock
Accumulated other comprehensive (loss) income
Retained earnings (Deficit)
Total
Non-controlling interests
Total equity
Balance at January 1, 2024
39,412
2,390
297,382
339,185
253,299
592,483
Total comprehensive income (loss) for the period:
Net income (loss)
-
-
18,089
18,089
10,225
28,314
Other comprehensive income (loss)
Foreign currency translation differences from
foreign operations and other, net of income tax
-
625
-
625
1,301
1,926
Total other comprehensive income (loss)
for the period
-
625
-
625
1,301
1,926
Total comprehensive income (loss) for the period
-
625
18,089
18,714
11,526
30,240
Transactions with owners, recorded directly in equity
Other movements in non-controlling interests and equity
-
-
72
72
31
103
Exchange of Topicus Coop ordinary units held by non-controlling interests to subordinate voting shares of Topicus
-
-
4,235
4,235
(4,235
)
-
Dividends paid to shareholders of the Company
-
-
(127,641
)
(127,641
)
-
(127,641
)
Dividends paid to non-controlling interests
-
-
-
-
(74,539
)
(74,539
)
Balance at March 31, 2024
39,412
3,016
192,136
234,565
186,082
420,646


Topicus.com Inc.
Condensed Consolidated Interim Statement of Changes in Shareholders' Equity (Deficiency)
(In thousands of euros, except per share amounts. Due to rounding, numbers presented may not foot.)
Unaudited
Three months ended March 31, 2023
Capital Stock
Accumulated other comprehensive (loss) income
Retained earnings (deficit)
Total
Non-controlling interests
Total equity
Balance at January 1, 2023
39,412
(232
)
226,919
266,099
201,685
467,784
Total comprehensive income (loss) for the period:
Net income (loss)
-
-
13,900
13,900
7,229
21,128
Other comprehensive income (loss)
Foreign currency translation differences from
foreign operations and other, net of income tax
-
(237
)
-
(237
)
(559
)
(796
)
Total other comprehensive income (loss) for the period
-
(237
)
-
(237
)
(559
)
(796
)
Total comprehensive income (loss) for the period
-
(237
)
13,900
13,663
6,669
20,332
Transactions with owners, recorded directly in equity
Other movements in non-controlling interests and equity
-
-
1
1
25
26
Balance at March 31, 2023
39,412
(469
)
240,820
279,763
208,380
488,143


Topicus.com Inc.
Condensed Consolidated Interim Statements of Cash Flows
(In thousands of euros, except per share amounts. Due to rounding, numbers presented may not foot.)
Unaudited
Three months ended March 31,
2024
2023
Cash flows from (used in) operating activities:
Net income (loss)
28,314
21,128
Adjustments for:
Depreciation
8,012
7,296
Amortization of intangible assets
31,672
27,960
Impairment of intangible and other non-financial assets
633
-
Bargain purchase (gain)
(323
)
-
Finance and other expenses (income)
4,998
4,950
Income tax expense (recovery)
8,085
8,338
Change in non-cash operating assets and liabilities
exclusive of effects of business combinations (note 16)
155,008
116,599
Income taxes (paid) received
(8,901
)
(12,279
)
Net cash flows from (used in) operating activities
227,497
173,993
Cash flows from (used in) financing activities:
Interest paid on lease obligations
(457
)
(306
)
Interest paid on other facilities
(3,161
)
(3,060
)
Net increase (decrease) in Topicus Revolving Credit Facility
105,000
(10,000
)
Proceeds from issuance of term and other loans
816
4,277
Repayments of term and other loans
(3,684
)
(68,445
)
Credit facility transaction costs
-
(63
)
Payments of lease obligations
(5,817
)
(5,263
)
Dividends paid to non-controlling interests
(74,539
)
-
Dividends paid to shareholders of the Company
(127,641
)
-
Net cash flows from (used in) in financing activities
(109,483
)
(82,860
)
Cash flows from (used in) investing activities:
Acquisition of businesses (note 4)
(36,542
)
(24,796
)
Cash obtained with acquired businesses (note 4)
7,024
972
Post-acquisition settlement payments, net of receipts
(4,214
)
(4,487
)
(Increase) decrease in restricted cash
(6,000
)
-
Property and equipment purchased
(2,654
)
(1,981
)
Net cash flows from (used in) investing activities
(42,386
)
(30,292
)
Effect of foreign currency on
cash and cash equivalents
(88
)
(348
)
Increase (decrease) in cash
75,540
60,493
Cash, beginning of period
179,059
136,772
Cash, end of period
254,599
197,265



Stock Information

Company Name: The Oncology Institute Inc.
Stock Symbol: TOI
Market: NASDAQ
Website: theoncologyinstitute.com

Menu

TOI TOI Quote TOI Short TOI News TOI Articles TOI Message Board
Get TOI Alerts

News, Short Squeeze, Breakout and More Instantly...